Selenium Intervention Registry Randomized Trial in Heart Failure

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4326 participants.

Also called NCT07543562

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 4,326 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07543562
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Norway, Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07543562. Randomized; triple masking; primary purpose treatment. Start 2026-04-01 (actual); primary completion 2030-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Selenium Intervention Registry Randomized Trial in Heart Failure
Acronym
SIRI-HF
Condition
Heart Failure
Condition
Heart Failure and Reduced Ejection Fraction
Condition
Heart Failure and Mildly Reduced Ejection Fraction
Condition
Heart Failure and Preserved Ejection Fraction
Condition
Selenium Supplementation
Condition
Selenium
Condition
Cognitive Functioning
Intervention (Dietary supplement)
Selenium Supplement
Intervention (Dietary supplement)
Placebo
Lead sponsor
Skane University Hospital (class: other)
Collaborator
Uppsala University (class: other)

Record details

Record id
cardio:ct-nct07543562
Content hash
be1b5747aeadc3e40c2febc7ec4de9f19ba29f218796848b37838e1af5ee4528